Reference
1. Messinis IE, Messini CI, Dafopoulos K. Novel aspects of the endocrinology of the menstrual cycle. Reproductive biomedicine online. 2014 Jun;28(6):714-22.
2. Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Human reproduction update. 2002 Mar-Apr;8(2):129-39.
3. Smacklon N, Fauser BC. Regulation of follicle development and novel approaches to ovarian stimulation for IVF. Human reproduction update. 2000 Jul-Aug;6(4):307-12.
4. Depalo R, Jayakrishan K, Garruti G, Totaro I, Panzarino M, Giorgino F, et al. GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). Reproductive biology and endocrinology : RB&E. 2012 Apr 13;10:26.
5. Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: Understanding advantages and limitations. Journal of Human Reproductive Sciences. 2014 July 1, 2014;7(3):170-4.
6. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Human reproduction update. 2006 Jul-Aug;12(4):333-40.
7. Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane database of systematic reviews. 2016 Apr 29;4:Cd001750.
8. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane database of systematic reviews. 2011 May 11(5):Cd001750.
9. Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertility and sterility. 2015 Jul;104(1):62-70.e3.
10. Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial. Medicine. 2016 Mar;95(9):e2939.
11. Dong J, Wang Y, Chai WR, Hong QQ, Wang NL, Sun LH, et al. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology. 2017 Jun;124(7):1048-55.
12. Beguería R, García D, Vassena R, Rodríguez A. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. Human Reproduction. 2019;34(5):872-80.
13. Veeck LL. Oocyte assessment and biological performance. Annals of the New York Academy of Sciences. 1988;541:259-74.
14. Lu X, Chen Q, Fu Y, Ai A, Lyu Q, Kuang YP. Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles. Scientific reports. 2016 Aug 8;6:31112.
15. Requena A, Cruz M, Ruiz FJ, Garcia-Velasco JA. Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin. Reproductive biology and endocrinology : RB&E. 2014 Jan 29;12:10.
16. Vanni VS, Vigano P, Quaranta L, Pagliardini L, Giardina P, Molgora M, et al. Are extremely high progesterone levels still an issue in IVF? Journal of endocrinological investigation. 2017 Jan;40(1):69-75.
17. Bu Z, Zhao F, Wang K, Guo Y, Su Y, Zhai J, et al. Serum progesterone elevation adversely affects cumulative live birth rate in different ovarian responders during in vitro fertilization and embryo transfer: a large retrospective study. PloS one. 2014;9(6):e100011.
18. Fair T, Lonergan P. The role of progesterone in oocyte acquisition of developmental competence. Reproduction in domestic animals = Zuchthygiene. 2012 Aug;47 Suppl 4:142-7.
19. O’Shea LC, Mehta J, Lonergan P, Hensey C, Fair T. Developmental competence in oocytes and cumulus cells: candidate genes and networks. Systems Biology in Reproductive Medicine. 2012 2012/04/01;58(2):88-101.
20. Urrego R, Herrera-Puerta E, Chavarria NA, Camargo O, Wrenzycki C, Rodriguez-Osorio N. Follicular progesterone concentrations and messenger RNA expression of MATER and OCT-4 in immature bovine oocytes as predictors of developmental competence. Theriogenology. 2015 Apr 15;83(7):1179-87.
21. Evans NP, Richter TA, Skinner DC, Robinson JE. Neuroendocrine mechanisms underlying the effects of progesterone on the oestradiol-induced GnRH/LH surge. Reproduction (Cambridge, England) Supplement. 2002;59:57-66.
22. Heikinheimo O, Gordon K, Williams RF, Hodgen GD. Inhibition of ovulation by progestin analogs (agonists vs antagonists): Preliminary evidence for different sites and mechanisms of actions. Contraception. 1996;53(1):55-64.
23. SOULES MR, STEINER RA, CLIFTON DK, COHEN NL, AKSEL S, BREMNER WJ. Progesterone Modulation of Pulsatile Luteinizing Hormone Secretion in Normal Women*. The Journal of Clinical Endocrinology & Metabolism. 1984;58(2):378-83.
24. Chabbert-Buffeta N, Skinner DC, Caraty A, Bouchard P. Neuroendocrine effects of progesterone. Steroids. 2000 2000/10/01/;65(10):613-20.
25. Mathieu d’Argent E, Ferrier C. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols. 2020 Feb 13;13(1):18.
26. Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Human reproduction update. 2017;23(2):211-20.
27. Evans MB, Parikh T, DeCherney AH, Csokmay JM, Healy MW, Hill MJ. Evaluation of the cost-effectiveness of ovulation suppression with progestins compared with GnRH analogs in assisted reproduction cycles. Reproductive biomedicine online. 2019;38(5):691-8.
28. Yu S, Long H, Chang HY-n, Liu Y, Gao H, Zhu J, et al. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles. Human Reproduction. 2017;33(2):229-37.